HALEOSLABSNSEHALEOS LABS LIMITEDLowNeutral
Announced Fri, 2 May · 18:31 IST

SMS Lifesciences India Limited has submitted the Exchange a copy of Srutinizers report of Postal Ballot along with a copy of minutes.

Board & Shareholder Meetings View source PDF

HALEOSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

SMS Lifesciences India Limited has disclosed the results of its postal ballot (e-voting from April 1 to April 30, 2025), in which all four special resolutions were passed with overwhelming majority. Resolution 1 approved the appointment of Mrs. Sundaramma Patibandla as Non-Executive and Women Independent Director for 5 years, with 99.9995% votes in favour. Resolution 2 approved the reappointment of Mr. TVVSN Murthy as Managing Director for a further 3 years, with 99.992% in favour. Resolution 3 approved the continuation of managerial remuneration to Executive Directors, with 99.992% in favour. Resolution 4 approved the postponement of the company's name change activity, with 99.9996% in favour. The promoter group, holding 68.02% stake, voted in favour on items 1 and 4 and abstained on items 2 and 3 where they were considered interested. Scrutinizer Mr. C. Sudhir Babu of CSB Associates certified the process as fair and transparent.

Likely market impact

Continuity in leadership is reaffirmed with the MD's reappointment and a new independent director onboarded, both with near-unanimous shareholder support. The name change postponement is a routine administrative decision and is unlikely to have any material impact on the stock price.